限时特惠,现货DIO模型不用等!


饮食诱导肥胖(diet-induced obesity,DIO)模型是肥胖机制研究与药物筛选的经典模型。

南模生物通过Research Diet D12492高脂饲料诱导成功构建了多种DIO大小鼠模型,能有效模拟人类肥胖及其代谢异常,为评估兼具减重、改善胰岛素抵抗及“减脂增肌”效应的候选药物提供可靠的临床前研究工具。

为回馈广大用户的信任与支持,南模生物现推出9折特惠活动,即日起至2026年3月31日,多种现货DIO模型可供选择。数量有限,先到先得!详情可见下图:

On Sale


关于我们

上海南方模式生物科技股份有限公司(Shanghai Model Organisms Center, Inc.,简称"南模生物"),成立于2000年9月,是一家上交所科创板上市高科技生物公司(股票代码:688265),始终以编辑基因、解码生命为己任,专注于模式生物领域,打造了以基因修饰动物模型研发为核心,涵盖多物种模型构建、饲养繁育、表型分析、药物临床前评价等多个技术平台,致力于为全球高校、科研院所、制药企业等客户提供全方位、一体化的基因修饰动物模型产品解决方案。






你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看
Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看